BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lowell JA, Farber MJ, Sultan K. Back to the drawing board: Overview of the next generation of combination therapy for inflammatory bowel disease. World J Gastroenterol 2024; 30(25): 3182-3184 [PMID: 39006384 DOI: 10.3748/wjg.v30.i25.3182]
URL: https://www.wjgnet.com/1007-9327/full/v30/i25/3182.htm
Number Citing Articles
1
Feng-Fei Wu, Lan Bai, Hui Yang, Wen-Ting Xie. New perspectives and prospects for the next generation of combination therapy in inflammatory bowel diseaseWorld Journal of Gastroenterology 2025; 31(5): 99462 doi: 10.3748/wjg.v31.i5.99462
2
M. Iborra, B. Botella, M. D. Martín‐Arranz, D. Ceballos, C. Martínez‐Pascual, A. Garrido, P. Varela, M. Moreta, E. Brunet‐Mas, Y. González‐Lama, E. Rodríguez‐González, M. Vicuña, J. P. Gisbert, I. Ordás, F. Argüelles‐Arias, J. Tosca‐Cuquerella, R. Vicente‐Lidón, M. Sierra‐Ausín, I. Rodríguez‐Lago, D. Martín‐Rodríguez, J. M. Paredes, B. Sicilia, I. García de la Filia, N. Jiménez, M. Barreiro‐de Acosta, E. Betoré, I. Ferrer‐Bradley, L. García‐Alles, J. M. Huguet, S. Castellet‐Farrús, M. J. García, A. Gutiérrez‐Casbas, Á. Ponferrada‐Díaz, L. Ramos, M. Calafat, I. Vera, C. Suárez‐Ferrer, E. Fernández‐Velado, S. Rodríguez‐Sánchez, A. Mínguez, A. Mancebo, J. Barrio, S. Lario, D. R. de La Cruz, Alejandro Hernández‐Camba, C. Rodríguez‐Gutiérrez, M. Chaparro, E. Ricart, L. Almenara‐Michelena, A. Balaguer, E. Domènech, P. Nos. Real‐World Effectiveness and Safety of Upadacitinib in Crohn's Disease: Insights From the Eneida RegistryUnited European Gastroenterology Journal 2026; 14(4) doi: 10.1002/ueg2.70223
3
Guillermo Arturo Cañadas-de la Fuente, Antonio M Caballero-Mateos. Game changer: How Janus kinase inhibitors are reshaping the landscape of ulcerative colitis managementWorld Journal of Gastroenterology 2024; 30(35): 3942-3953 doi: 10.3748/wjg.v30.i35.3942
4
Li-Xuan Sang, Zi-Ning Zhang. Dual-targeted treatment for inflammatory bowel disease: Whether fecal microbiota transplantation can be an important part of itWorld Journal of Gastroenterology 2024; 30(36): 4025-4030 doi: 10.3748/wjg.v30.i36.4025
5
Fu-Shan Tang, Yan-Miao Liu, Hang Zhang, Mei Nie, Jia-Wang Yan. Strengths, weaknesses, opportunities, and threats analysis of combination therapy for inflammatory bowel diseaseWorld Journal of Gastroenterology 2025; 31(9): 100607 doi: 10.3748/wjg.v31.i9.100607
6
Mei Kang, Daiyuan Tang, Wei Huang, Mingxia Zhou, Qiang Ma, Yining Lan, Deyi Chen, Ya Li, Bing Han. Emerging role of Itaconate in inflammatory bowel disease: From multitarget Immunometabolic mechanisms to therapeutic translationInternational Immunopharmacology 2025; 166 doi: 10.1016/j.intimp.2025.115632